[144] Confluent, Inc. SEC Filing

Rhea-AI Filing Summary

Confluent, Inc. (CFLT) filed a Form 144 notifying the proposed sale of 500,000 common shares by a person holding founders shares acquired on 09/01/2014. The filing reports an aggregate market value of $10,120,000.00 and shows 291,931,187 shares outstanding, with an approximate sale date of 09/09/2025 on NASDAQ. The securities were originally issued by the company to the filer (issuer) and payment was recorded as of the acquisition date; no sales by the filer in the prior three months were reported. The filer affirms no undisclosed material adverse information and includes standard Rule 10b5-1 notice language.

Positive

• Filing compliance: Form 144 properly discloses proposed sale details including quantity, value, acquisition date, and intended exchange.
• No recent sales reported: The filer reported "Nothing to Report" for securities sold in the past three months, suggesting this is not part of frequent insider selling.

Negative

• Insider-related sale: The transaction involves founders shares, which investors may view unfavorably depending on context.
• Limited context: The filing does not state the seller's current role or reason for sale, restricting interpretation of motives.

Insights

Securities Analyst

TL;DR: Insider/related-party sale of 500,000 shares valued at $10.12M; small relative to outstanding shares, likely modest market impact.

The filing documents a proposed disposition of 500,000 common shares originally issued as founders shares on 09/01/2014. At an aggregate market value of $10.12 million against 291.93 million shares outstanding (~0.17%), the sale appears immaterial to total share count, reducing the likelihood of a significant market move solely from this transaction. The absence of reported sales in the prior three months indicates this is not part of recent serial selling. The filer’s confirmation regarding material non-public information and the inclusion of 10b5-1 related fields are standard controls that support compliance.

Corporate Governance Expert

TL;DR: Filing shows rule-compliant disclosure of an insider-related sale; governance controls and disclosure appear followed.

This Form 144 discloses a sale of founder-issued shares by a person for whose account the securities are to be sold, with required details on acquisition, payment, and planned sale venue/date. The statement that no material non-public information is known and the reference to 10b5-1 plan adoption date (blank here) are important governance affirmations. The document does not include plan adoption date or additional context about the seller’s role, so assessment of motivations or governance implications is limited to the filing’s confirmations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	500000	10120000.00	291931187	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2014	Founders Shares	Issuer			500000	09/01/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What transaction does Confluent (CFLT) disclose in this Form 144?

The filing notifies a proposed sale of 500,000 common shares with an aggregate market value of $10,120,000.00, to be sold on NASDAQ on or about 09/09/2025.

When were the shares being sold originally acquired?

The shares were acquired as founders shares on 09/01/2014, with payment and acquisition recorded on that same date.

How large is the proposed sale relative to Confluent's outstanding shares?

The sale of 500,000 shares is against 291,931,187 outstanding shares, approximately 0.17% of the outstanding share count.

Did the filer report any securities sold in the past three months?

No; the filing lists "Nothing to Report" for securities sold during the past three months.

Does the filer assert absence of material non-public information?

Yes; the filer represents by signing the notice that they do not know any material adverse information not publicly disclosed.